<DOC>
	<DOCNO>NCT00159744</DOCNO>
	<brief_summary>Bipolar disorder characterize mood swing range high ( manic ) low ( depress ) state . Sometimes , symptoms depression mania present ( mixed episode ) . Asenapine investigational medication treatment manic mixed episode bipolar disorder . This 3-week study test safety efficacy medication . Patients receive either asenapine , olanzapine ( medication already approve treatment bipolar mania ) , placebo ( active medication ) . Patients require stay hospital least first seven day treatment . Patients complete 3 week study may eligible continue extension study additional 9 ( study A7501006 ) 49 ( study A7501007 ) week .</brief_summary>
	<brief_title>3-Week Study Asenapine , Olanzapine Placebo Treatment Bipolar Mania ( P07008 )</brief_title>
	<detailed_description />
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Asenapine</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Have DSMIV diagnosis bipolar I disorder , current episode manic mixed . Patients unstable medical condition clinically significant laboratory abnormality patient rapid cyclers ( ie . 4 ( include current ) mood episode past 12 month ) ; psychiatric disorder bipolar I disorder primary diagnosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>